The Dubai-born golfer will next compete for a coveted PGA Tour card at next month's Final Stage in Florida
sports2 hours ago
India's drug regulator on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal Covid-19 vaccine to be used as a booster shot, according to a Mint report, which cited ANI.
The vaccine maker submitted the late-stage trial application to the Drugs Controller General of India (DCGI) in December, adding that an intranasal vaccine as a booster dose will be easier to administer in mass vaccination campaigns.
The company had in August received the Drug Controller General of India's (DCGI's) nod for conducting phase 2 clinical trials of the nasal vaccine.
"DCGI's Subject Expert Committee has granted 'in principle' approval to Bharat Biotech for the conduct of 'Phase III superiority study and Phase III booster dose study' for its intranasal COVID vaccine and has asked it to submit protocols for approval," according to the report on Wednesday.
Bharat Biotech and DCGI did not immediately respond to Reuters requests for comment.
As a precautionary measure in light of rising Omicron coronavirus variant cases across the country, India approved the administration of Covid-19 booster shots on Christmas, with healthcare and frontline workers set to receive them from January 10.
The country is yet to approve the use of Bharat Biotech's intranasal vaccine, BBV154. In August, BBV154 received regulatory approval for mid- to late-stage trials. Local media had reported the mid-stage trial has completed.
India's inoculation drive so far has been dominated by a domestically produced version of the AstraZeneca Covid-19 shot by Serum Institute of India and Bharat Biotech's inactivated vaccine Covaxin, both administered through injections.
On Wednesday, the country reported 58,097 new coronavirus cases, twice the number seen only four days ago, taking its total caseload to over 35 million.
BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. Bharat Biotech has in-licensed the technology from Washington University in St Louis, the US.
ALSO READ:
The company reports that the doses of the vaccine administered to healthy volunteers in the phase-1 clinical trial have been well tolerated. No serious adverse events were reported, the DBT had said.
The Dubai-born golfer will next compete for a coveted PGA Tour card at next month's Final Stage in Florida
sports2 hours ago
'These modern features are designed to improve traffic and security operations, elevate fieldwork quality, ensure high responsiveness', a top official said
transport2 hours ago
The night market is located near major hotels in Deira, and visitors can also enjoy free entertainment from different Filipino singers and comedians
uae3 hours ago
It will be humid by night and Sunday morning with a probability of fog or mist formation over some internal areas
weather3 hours ago
The Dubai Maritime Authority is responsible for issuing licences related to all marine activities in the emirate
life and living5 hours ago
Both researchers underscored the importance of mentorship and representation for aspiring female scientists in the region
uae5 hours ago
'Prolonged exposure to traffic stress can increase cortisol and other stress hormones, leading to anxiety, depression, headaches, and even heart disease,' a clinical psychologist warned
transport5 hours ago
Stricter requirements were put in place to prevent potential misuse of visit visas and ensure that applicants can sustain themselves during their stay
uae5 hours ago